Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SalT Reduction InterVEntion: Examination of the Metabolic, Behavioral and Health Consequences of Reducing Salt Intake. A Randomized Controlled Trial in a Real Life Setting

NCT03810885 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT03810885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03810885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SalT Reduction InterVEntion: Examination of the Metabolic, Behavioral and Health Consequences of Reducing Salt Intake. A Randomized Controlled Trial in a Real Life Setting
Lead sponsor
Bispebjerg Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2018
Completion date
April 30, 2019
Enrollment
316 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

salt intake